Spectacles improve night driving in presbyopes

Article

Spectacle correction improves distance vision during night-time driving in presbyopes but has a negative impact on near vision.

Spectacle correction improves distance vision during night-time driving in presbyopes but has a negative impact on near vision, according to a recent study published in Investigative Ophthalmology & Visual Science.

The research team, led by Dr Byoung Sun Chu of Queensland University of Technology, Brisbane, Australia, examined 11 presbyopes who had only previously used reading spectacles as a correction method. Repeated measurements were taken at night-time on a closed-road circuit while each subject wore four different types of power matched vision corrections in a randomized order. The corrective methods used were single-vision distance lenses (SV), progressive addition spectacle lenses (PAL), monovision contact lenses (MV) and multifocal contact lenses (MTF CL).

Each patient's ability to detect and avoid low-contrast road hazards, recognition of road signs and near targets and legibility distance of street signs was measured. Additionally, the ability for the study group to keep within their lanes and the overall driving time were measured along with eye movement data (fixation duration and number of fixations).

It was concluded that presbyopic correction worn by naive wearers affected night-time driving ability with PAL and SV giving the best results for distance tasks but SV correction negatively affected the near dashboard viewing targets. It was also shown that MTF CL gave the shortest legibility distance for street signs and the longest fixation times.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.